Imrich Blasko

3.3k total citations
35 papers, 2.5k citations indexed

About

Imrich Blasko is a scholar working on Physiology, Psychiatry and Mental health and Neurology. According to data from OpenAlex, Imrich Blasko has authored 35 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Physiology, 13 papers in Psychiatry and Mental health and 10 papers in Neurology. Recurrent topics in Imrich Blasko's work include Alzheimer's disease research and treatments (26 papers), Dementia and Cognitive Impairment Research (11 papers) and Neuroinflammation and Neurodegeneration Mechanisms (7 papers). Imrich Blasko is often cited by papers focused on Alzheimer's disease research and treatments (26 papers), Dementia and Cognitive Impairment Research (11 papers) and Neuroinflammation and Neurodegeneration Mechanisms (7 papers). Imrich Blasko collaborates with scholars based in Austria, Germany and Netherlands. Imrich Blasko's co-authors include Beatrix Grubeck‐Loebenstein, Florentine Marx, B. Grubeck‐Loebenstein, Georg Kemmler, Piet Eikelenboom, Robert Veerhuis, Michaela Stampfer‐Kountchev, Josef Marksteiner, M. Saurwein-Teissl and Tobias Hartmann and has published in prestigious journals such as The Journal of Immunology, The FASEB Journal and FEBS Letters.

In The Last Decade

Imrich Blasko

34 papers receiving 2.5k citations

Peers

Imrich Blasko
Giuseppe Faraco United States
Candice M. Brown United States
Juhyun Song South Korea
Smita Zaheer United States
Monica M. Santisteban United States
Giuseppe Faraco United States
Imrich Blasko
Citations per year, relative to Imrich Blasko Imrich Blasko (= 1×) peers Giuseppe Faraco

Countries citing papers authored by Imrich Blasko

Since Specialization
Citations

This map shows the geographic impact of Imrich Blasko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Imrich Blasko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Imrich Blasko more than expected).

Fields of papers citing papers by Imrich Blasko

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Imrich Blasko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Imrich Blasko. The network helps show where Imrich Blasko may publish in the future.

Co-authorship network of co-authors of Imrich Blasko

This figure shows the co-authorship network connecting the top 25 collaborators of Imrich Blasko. A scholar is included among the top collaborators of Imrich Blasko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Imrich Blasko. Imrich Blasko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Blasko, Imrich, Michaela Defrancesco, Herbert Oberacher, et al.. (2021). Plasma phosphatidylcholines and vitamin B12/folate levels are possible prognostic biomarkers for progression of Alzheimer's disease. Experimental Gerontology. 147. 111264–111264. 18 indexed citations
2.
Defrancesco, Michaela, Josef Marksteiner, W. Wolfgang Fleischhacker, & Imrich Blasko. (2015). Use of Benzodiazepines in Alzheimer’s Disease: A Systematic Review of Literature. The International Journal of Neuropsychopharmacology. 18(10). pyv055–pyv055. 75 indexed citations
3.
Kemmler, Georg, et al.. (2012). Treatment patterns in inpatients with bipolar disorder at a psychiatric university hospital over a 9-year period. International Clinical Psychopharmacology. 27(5). 256–266. 18 indexed citations
4.
Blasko, Imrich, Georg Kemmler, Susanne Jungwirth, et al.. (2012). Conversion from mild cognitive impairment to dementia: Influence of folic acid and vitamin B12 use in the vita cohort. The journal of nutrition health & aging. 16(8). 687–694. 49 indexed citations
5.
Blasko, Imrich, Georg Kemmler, Susanne Jungwirth, et al.. (2011). Prospective study on association between plasma amyloid beta-42 and atherosclerotic risk factors. Journal of Neural Transmission. 118(5). 663–672. 12 indexed citations
6.
Blasko, Imrich, Georg Kemmler, Susanne Jungwirth, et al.. (2010). Plasma Amyloid Beta-42 Independently Predicts Both Late-Onset Depression and Alzheimer Disease. American Journal of Geriatric Psychiatry. 18(11). 973–982. 63 indexed citations
7.
Blasko, Imrich, Susanne Jungwirth, K. A. Jellinger, et al.. (2007). Effects of medications on plasma amyloid beta (Aβ) 42: Longitudinal data from the VITA cohort. Journal of Psychiatric Research. 42(11). 946–955. 19 indexed citations
8.
Blasko, Imrich, Elisabeth M. Weiss, Georg Kemmler, et al.. (2006). Cognitive deterioration in Alzheimer’s disease is accompanied by increase of plasma neopterin. Journal of Psychiatric Research. 41(8). 694–701. 47 indexed citations
9.
Blasko, Imrich, Georg Kemmler, Wolfgang Krampla, et al.. (2005). Plasma amyloid β protein 42 in non-demented persons aged 75 years: Effects of concomitant medication and medial temporal lobe atrophy. Neurobiology of Aging. 26(8). 1135–1143. 39 indexed citations
11.
Blasko, Imrich, Thomas Bodner, Thomas Walch, et al.. (2004). Efficacy of Donepezil Treatment in Alzheimer Patients with and without Subcortical Vascular Lesions. Pharmacology. 72(1). 1–5. 13 indexed citations
12.
Blasko, Imrich & Beatrix Grubeck‐Loebenstein. (2003). Role of the Immune System in the Pathogenesis, Prevention and Treatment of Alzheimer??s Disease. Drugs & Aging. 20(2). 101–113. 89 indexed citations
13.
Saurwein-Teissl, M., Florentine Marx, Imrich Blasko, et al.. (2002). Lack of Antibody Production Following Immunization in Old Age: Association with CD8+CD28− T Cell Clonal Expansions and an Imbalance in the Production of Th1 and Th2 Cytokines. The Journal of Immunology. 168(11). 5893–5899. 382 indexed citations
14.
Blasko, Imrich, Gerhard Ransmayr, Robert Veerhuis, Piet Eikelenboom, & Beatrix Grubeck‐Loebenstein. (2001). Does IFNγ play a role in neurodegeneration?. Journal of Neuroimmunology. 116(1). 1–4. 31 indexed citations
15.
Blasko, Imrich, Robert Veerhuis, Michaela Stampfer‐Kountchev, et al.. (2000). Costimulatory Effects of Interferon-γ and Interleukin-1β or Tumor Necrosis Factor α on the Synthesis of Aβ1-40 and Aβ1-42 by Human Astrocytes. Neurobiology of Disease. 7(6). 682–689. 212 indexed citations
16.
Blasko, Imrich, A. Sztankay, P. Lukáš, & Beatrix Grubeck‐Loebenstein. (2000). Decreased thyroid peroxidase expression in cultured thyrocytes after external gamma irradiation. Experimental and Clinical Endocrinology & Diabetes. 108(2). 138–141. 6 indexed citations
17.
Wick, Georg, Pidder Jansen‐Dürr, Peter Berger, Imrich Blasko, & Beatrix Grubeck‐Loebenstein. (2000). Diseases of aging. Vaccine. 18(16). 1567–1583. 111 indexed citations
18.
Schwingshackl, Andreas, Imrich Blasko, Eberhard Steiner, et al.. (1998). Sex Steroids Do Not Prevent Amylin-Induced Apoptosis in Human Cells. Experimental Cell Research. 241(1). 265–268. 6 indexed citations
19.
Blasko, Imrich, et al.. (1998). The Production of the Alzheimer Amyloid Precursor Protein (APP) in Extraneuronal Tissue Does Not Increase in Old Age. The Journals of Gerontology Series A. 53A(3). B186–B190. 9 indexed citations
20.
Blasko, Imrich, Thomas Schmitt, Eberhard Steiner, Klemens Trieb, & Beatrix Grubeck‐Loebenstein. (1997). Tumor necrosis factor α augments amyloid β protein (25–35) induced apoptosis in human cells. Neuroscience Letters. 238(1-2). 17–20. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026